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As emotion regulation deficits have been implicated in psychotic disorders, it is imperative
to investigate not only the effect of regulation strategies but also how they are used. One
such strategy is expressive suppression, the inhibition of emotion-expressive behavior,
which may be influenced by social context. Therefore, this study aimed to investigate
whether the use of expressive suppression was associated with social context and affect
in daily life and if this differed between patients with psychosis and controls. Multilevel
models using experience sampling method (ESM) data of 34 patients with psychotic disor-
ders and 53 controls from the Genetic Risk and Outcome in Psychosis (GROUP) project
were conducted. Expressive suppression and social context were assessed once a day
for six days and daily affect was averaged per participant per day. Social context was sig-
nificantly associated with the use of expressive suppression in daily life, so that the use of
expressive suppression differed when in the presence of familiar versus non-familiar com-
pany when receiving negative feedback. This finding did not differ between patients and
controls. This demonstrates that taking the situation into account when studying expres-
sive suppression, and emotion regulation in general, may improve our understanding of
how regulation takes place.
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Introduction
Individuals with psychosis experience deficits in adaptive emotion regulation, which may be
related to psychotic symptoms and other difficulties [1]. Furthermore, maladaptive emotion
regulation strategies have been shown to mediate the path between adverse life events and pos-
itive psychotic symptoms, such as delusion proneness and hallucinations [2] and to sometimes
increase the severity of hallucinations [3]. Therefore, it is important to elucidate the nature of
emotion regulation in psychosis, including how patients with psychotic disorders employ
emotion regulatory strategies.
Broadly, emotion regulation refers to goal-directed behaviors meant to influence various
aspects of emotion generation [4, 5]. These behaviors can affect which emotions individuals
experience, when and how they are experienced, and how they are expressed [6]. Specifically,
response modulation is a type of emotion regulation strategy that focuses on influencing the
emotional response after the emotion is developed [4]. One such response modulation is
expressive suppression, which focuses on inhibiting or reducing emotion-expressive behavior
when emotionally aroused [7]. While expressive suppression is effective in decreasing the
behavioral expression of negative emotions, it has been shown to be ineffective in the regula-
tion of negative emotions as it tends to increase negative affect and decrease positive affect [7–
9]. Thus, the overuse of expressive suppression may be maladaptive as is supported by findings
that habitual expressive suppression is associated with worse well-being [7, 10].
There is mixed evidence on the possible overreliance on expressive suppression in those
who have psychotic disorders. Some research suggests that they are more likely to use expres-
sive suppression in comparison to healthy controls [11, 12] whereas other research finds no
differences [13, 14]. However, many previous studies assess expressive suppression as a habit-
ual concept, but the use of expressive suppression may vary greatly within-person according to
the context [9]. Therefore, it is necessary to also investigate expressive suppression as a variable
strategy to elucidate how individuals with psychosis employ expressive suppression.
Emotion regulation is not solely an individual process but may be influenced by social con-
text and interpersonal interactions [15, 16]. In interpersonal interactions, individuals may rely
on a safety signal from the other person to properly share their emotions and appraise the
event that caused their emotions, meaning that the emotion regulation is response-dependent
as it relies on another person’s feedback [15]. This may also apply to expressive suppression.
There is, however, a dearth of research on how social context can influence the use of expres-
sive suppression. Research that has investigated the influence of social context on the use of
expressive suppression has found that individuals tend to use more suppression when they are
lower in social hierarchy [17]. In this case, expressive suppression could protect against nega-
tive outcomes of showing expression in “unsafe” situations, such as when one is low in the
social hierarchy. However, it could be that if one suppresses their emotional expression in
“safe” situations, one feels a sense of inauthenticity that may lead to negative consequences [7].
Furthermore, a recent study demonstrated in a sample of college students that expressive sup-
pression can indeed be influenced by company in that less expressive suppression is used in
familiar company [18].
However, the influence of social context on the use of expressive suppression and the
influence of context on the emotional consequences of expressive suppression have yet to be
explored in patients with psychosis. Patients with psychosis tend to have social cognitive def-
icits, such as with facial affect recognition [19], which may impact how they perceive their
social environment. Furthermore, patients tend to have a higher negative reactivity to daily
life stressors [20], and so expressive suppression may have a more marked effect on their
affect as compared to controls.
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Therefore, the present study aimed to investigate expressive suppression as a response-
dependent strategy in the context of negative events; specifically, whether the use of expressive
suppression is influenced by social context and how this impacts on affect for patients with
psychosis and controls in daily life. In doing so, expressive suppression was assessed as a
dynamic strategy while acknowledging the interpersonal aspect of emotion regulation. This
could perhaps provide some insight into how individuals with psychotic disorders use expres-
sive suppression, allowing for interventions that target this.
The study investigated two questions: 1) the association between two aspects of social con-
text (company and feedback) and the use of expressive suppression and whether this differs
between patients and controls, and 2) the association between expressive suppression and
daily affect according to social context (company and feedback) and whether this differs
between patients and controls.
It was expected that familiar company and/or positive feedback would be associated with
lower expressive suppression. Furthermore, this was expected to differ between patients and
controls, such that the association between social context and expressive suppression will be
greater in controls than in patients. It was also hypothesized that higher expressive suppres-
sion with familiar company and/or positive feedback (e.g., “safe” situations) would be related
to higher negative affect and lower positive affect. It was expected that this would also differ
between patients and controls in that the association between expressive suppression and
affect will be greater in patients than in controls.
Methods
Participants
The sample of this study consisted of 34 patients with psychotic disorders and 53 controls
from wave 3 (six-year follow-up) of the Genetic Risk and Outcome in Psychosis (GROUP)
project [21]. Data pertain to follow-up measures of the ongoing longitudinal study (GROUP)
in Europe. In selected representative geographical areas in the Netherlands and Belgium,
patients were identified through clinicians whose caseload was screened for inclusion criteria.
Subsequently, a group of patients presenting consecutively at these services either as out-
patients or in-patients were recruited for the study. Controls were selected through a system of
random mailings to addresses in the catchment areas of the cases. The full GROUP sample
consisted of 3684 participants (patients, relatives, and controls) between the ages of 16–50
years, excluding parents. Patients had a diagnosis of a schizophrenia or psychotic disorder as
per the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) cri-
teria [22], and the healthy controls had to have no lifetime psychotic disorder as well as no
first- or second-degree relative with a psychotic disorder [21]. All participants had to be able
and willing to provide written informed consent, which was obtained from all participants
before the start of the first assessment [21].
The study protocol was approved centrally by the Ethical Review Board of the University
Medical Center Utrecht (#NL46405.018.13) and subsequently by local review boards of each
participating institute: Academic Psychiatric Centre of the Academic Medical Center and the
mental health institutions: GGZ Ingeest, Arkin, Dijk en Duin, GGZ Rivierduinen, Erasmus
Medical Centre, GGZ Noord Holland Noord; University Medical Center Groningen and the
mental health institutions: Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGNet
Warnsveld, Yulius Dordrecht and Parnassia psycho-medical center The Hague; Maastricht
University Medical Centre and the mental health institutions: GGzE, GGZ Breburg, GGZ
Oost-Brabant, Vincent van Gogh voor Geestelijke Gezondheid, Mondriaan, Virenze riagg,
Zuyderland GGZ, MET ggz, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University
PLOS ONE Expressive suppression and social context
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of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ
Rekem; University Medical Center Utrecht and the mental health institutions Altrecht, GGZ
Centraal and Delta. All participants in this study gave written informed consent after full ver-
bal and written information about the study, and each participant is identified with a unique
research identification to maintain confidentiality of data.
This study focused on a sample of GROUP that participated in an experience sampling
method study (ESM), which had a full sample of 465 participants (patients, relatives, and con-
trols). Participants were included in the final sample if they had sufficient ESM data on expres-
sive suppression and social feedback (i.e., completed a minimum of five evening
questionnaires and reported having a minimum of three conversations; n = 166). Further-
more, only the observations of participants who were in either the control or patient group
were included, leading to the final sample (n = 87).
Measures
Demographics and clinical information. Demographic and clinical information regard-
ing gender, age, ethnicity, and group (i.e., control versus patient) for the participants was
acquired from the GROUP database, release number 1.0.
The following items were from the ESM protocol that the patients completed wave 3 of the
GROUP study. ESM is a structured diary method with high ecological validity that uses both
self-report scales and open-ended questions on the participant’s feelings, thoughts, and symp-
toms as well as the contexts in which these occur [23]. This method allows for the capturing of
moment-to-moment and daily patterns within individuals, giving room for heterogeneity of
patterns whilst also enabling the analysis of patterns at the group level. Participants are ran-
domly prompted by a beep signal to complete the ESM questionnaire ten times a day and a
separate evening questionnaire once a day for six days. The evening questionnaire asked par-
ticipants questions regarding a negative and a positive event that occurred during the day.
The items of the evening questionnaire about to the negative event were used.
Affect. Participants rated adjectives about affect on a 7-point Likert scale (1 = not at all to
7 = very much) ten times a day. The positive affect scale consists of four adjectives (cheerful,
relaxed, satisfied, and enthusiastic), and the negative affect scale consists of five adjectives
(insecure, down, lonely, anxious, annoyed).
Expressive suppression. Expressive suppression was measured in the evening questionnaire
(i.e., once a day) with one item “I showed my emotions” that was rated on a 7-point Likert scale
(1 = not at all to 7 = very much). This item was prompted as a coping strategy in relation to the
negative event indicated by the participant. A lower rating denotes more expressive suppression.
Social context (company and feedback). Social context was assessed with two different
items from the evening questionnaire. The first item asked the participant about their com-
pany (“With whom was this?” with “this” referring to the most negative event that occurred
that day), and the answers were categorized into two types: with familiar individuals (family
members, friends, partner) and with non-familiar individuals work colleagues, acquaintances,
strangers, other; in accordance with Verdoux, Husky [24]. The category of “alone” was not
included in analyses as this study focused on social interactions. The second item assessed
feedback (“This person responded with understanding”) on a 7-point Likert scale (1 = not at
all to 7 = very much), which was in relation to a conversation about the negative event.
Procedure
This study analyzed the ESM data from a sample of the GROUP wave 3 (six-year follow-up)
database containing results from participants across different sites. Except for the diagnostic
PLOS ONE Expressive suppression and social context
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instrument, the same measures were used across all the sites and the data was gathered into a
centralized coded database [21]. The assessments were administered by trained research assis-
tants and took place at a mental health center or academic center. Permission to use the data
was first acquired from the GROUP coordinators before proceeding with data analyses. Once
that was completed, analyses of the data were conducted with the Stata 13.1 software program.
To associate the daily repeated measurements of affect with the single measures of the even-
ing questionnaire items, such as expressive suppression, the scores of the positive and negative
affect items were aggregated separately per day per participant. This was done because the
evening questionnaire itself did not include questions on affect; therefore, a daily positive
affect sum score and a daily negative affect sum score were used in relation to the evening
questionnaire.
Statistical analysis
To test the hypotheses, multilevel analyses were conducted, which are suitable for the hierar-
chical nature of ESM data in which the observations (level-1) are nested within individuals
(level-2; [25]). For all statistical tests, an alpha level of 0.05 was used.
Before testing the hypotheses, basic descriptive statistics were conducted to determine the
sample characteristics. Gender, age, and ethnicity were considered a priori as potential con-
founders. They were analyzed with linear regression or chi-square tests as appropriate to test
for group differences to determine if they were significantly different and, therefore, needed to
be included as a confounder. The main ESM variables (e.g., expressive suppression) were
aggregated per participant and tested for group differences with regression, independent sam-
ple t-test for unequal variances, or chi-square tests.
The multilevel model of the association of social context on expressive suppression was ana-
lyzed with company as a categorical predictor, feedback as a continuous predictor, and expres-
sive suppression as the outcome. Using a likelihood ratio test, this model was tested against a
model with the interaction company x feedback as a predictor and expressive suppression as
the outcome. Group was added as a level-2 moderator in a subsequent analysis, and the main
effects model was tested against the interaction effect model. Interactions were probed by
investigating the simple slopes of marginal effects.
The association between expressive suppression and affect depending on social context
was analyzed with separate multilevel models with the aggregated daily positive affect and the
aggregated daily negative affect as the outcomes. The predictors were interaction terms for
social context and expressive suppression (i.e., company x expressive suppression, feedback x
expressive suppression, company x feedback x expressive suppression). The interactions mod-
els were tested against the main effects models using likelihood ratio tests. To avoid complex
interactions, associations were stratified between patients and controls to investigate these
relationships in the two groups.
Results
Sample characteristics
Table 1 shows the sample characteristics. Participants in the control group were older than
those in the patient group, and there were more women than men in each group and in the
sample overall. The groups did not exhibit a significant difference in ethnicity, however, and
the sample consisted mostly of Caucasian participants. Therefore, age and gender were included
as confounders in all the multilevel models. It should also be noted that 27 out of 34 patients
were in remission. Furthermore, there was no significant difference in the use of expressive sup-
pression between patients and controls. The groups also did not vary in in terms of company
PLOS ONE Expressive suppression and social context
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nor feedback. However, patients reported experiencing less positive affect and more negative
affect compared to controls. Lastly, remitted patients and non-remitted patients did not have
any significant differences regarding the main outcome measures and there were no differences
in any of the main outcome variables between diagnoses in the patient group.
Association between social context and the use of expressive suppression
The interaction between company and feedback was significantly associated with the use of
expressive suppression and exhibited better model fit according to the likelihood ratio test.
Estimation of the simple slopes of marginal effects demonstrated that when receiving positive
feedback, company did not matter for expressive suppression (B = 0.21, 95% CI [-0.45, 0.88], p
= .527), but when receiving negative feedback, participants used less expressive suppression in
familiar company as compared to non-familiar company (B = -2.02, 95% CI [-3.43, -0.62], p =
.005). Furthermore, there was no effect of group on the association between social context
(company and feedback) and expressive suppression. These results are demonstrated in
Table 2.
Table 1. Sample characteristics.
Patients (n = 34) Controls (n = 53) Test statistic p
Age (years), mean (SD) 33.9 (7.5) 39.8 (12.1) F = 6.39, df = 1 .013
Gender, n (%) χ 2 = 10.48, df = 1 .001
Male 15 (44.1) 7 (13.2)
Female 19 (55.8) 46 (86.8)
Ethnicity, Caucasian (%) 32 (94.1) 52 (98.1) χ 2 = 0.99, df = 1 .319
Diagnosis, n (%)
SZ, paranoid type 12 (35.3)
SZ, undifferentiated type 2 (5.9)
Psychosis with delusions 1 (2.9)
Psychosis NOS 5 (14.7)
Schizoaffective disorder 14 (41.2)
In remission, n (%) 27 (79.4)
Expressive suppression, mean (SD) 3.9 (1.2) 3.8 (1.3) F = 2.03, df = 1 .155
Type of diagnosisa F = 2.02, df = 4 .118
Remission status (yes/no)a t = -0.32, df = 8.39 .754
Company, n (%) χ 2 = 0.10, df = 1 .749
Familiar 82 (59.9) 155 (61.5)
Non-familiar 55 (40.1) 97 (38.5)
Type of diagnosisa χ 2 = 5.44, df = 4 .245
Remission status (yes/no)a χ 2 = 0.62, df = 1 .432
Feedback, mean (SD) 5.3 (0.9) 5.4 (0.7) F = 0.56, df = 1 .453
Daily PA, mean (SD) 126.8 (41.4) 148.7 (43.0) F = 23.52, df = 1 <.001
Type of diagnosisa F = 1.83, df = 4 .149
Remission status (yes/no)a t = -1.52, df = 12.54 .154
Daily NA, mean (SD) 59.4 (21.2) 54.0 (21.0) F = 5.81, df = 1 .016
Type of diagnosisa F = 1.25, df = 4 .314
Remission status (yes/no)a t = -0.15, df = 7.04 .887
SD, standard deviation; df, degrees of freedom
a Statistical difference between diagnoses and state of remission analyzed only in patients
https://doi.org/10.1371/journal.pone.0230102.t001
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Association of expressive suppression and affect depending on social
context
The results indicated that there was no significant interaction effect of expressive suppression
with company and/or feedback on positive affect (Tables 3 and 4). These effects were non-sig-
nificant for patients and for controls.
There was also no significant interaction effect of expressive suppression with company
and/or feedback on negative affect (Tables 5 and 6). These effects were non-significant for
patients and for controls.
Discussion
In this study, expressive suppression was investigated in daily life as a response-dependent
interpersonal emotion regulation strategy. This was done by analyzing the association between
the daily measurement of expressive suppression to positive affect, negative affect, and social
context (company and feedback) associated with a negative event on which participants
reported.
Supporting the hypothesis of expressive suppression being associated with social context,
an interesting interaction between company and feedback was demonstrated. Company mat-
tered for negative feedback in that less expressive suppression was used in familiar company as
compared to non-familiar company. However, company did not matter for expressive sup-
pression when there was positive feedback. Therefore, a possible interpretation of these find-
ings is that participants feel comfortable enough to express their emotions when with familiar
company, regardless of how the other person responds, but when with non-familiar company,
participants only feel comfortable expressing their emotions when they receive positive
feedback.
These findings point to the social nature of expressive suppression. It can be argued that in
comparison to other emotion regulation techniques, such as cognitive reappraisal and distrac-
tion, expressive suppression may rely more on social context as was also found in the English,
Lee [18] study. Because individuals with psychosis tend to have impairments in facial affect
recognition [19], which could have impacted how patients perceived the feedback received, we
thought that patients and controls might differ in their sensitivity to the social context. How-
ever, the results indicate that there was no significant difference between patients and controls.
Table 2. The Association between social context and the use of expressive suppressiona.
Outcome: Expressive Suppression
Social Context adj. β (95% CI) p LR testb,c
χ2 (df) p
Company -2.40 (-4.11–-0.69) .006
Feedback -0.16 (-0.35–0.03) .103
Company x Feedback 0.37 (0.06–0.69) .020 5.34 (1) .021
Company x Group -1.04 (-4.6–2.52) .567
Feedback x Group -0.05 (-0.45–0.35) .797
Company x Feedback x Group 0.16 (-0.49–0.81) .633 6.15 (4) .188
CI, confidence interval; df, degrees of freedom; LR, likelihood ratio
a Adjusted for age and gender
b LR test (a nested in b): model a (company, feedback) vs model b (company x feedback)
c LR test (a nested in b): model a (company, feedback, group) vs model b (company x feedback x group)
https://doi.org/10.1371/journal.pone.0230102.t002
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Finally, there was no association between expressive suppression and either positive or
negative affect according to social context. This may be due to methodology rather than a
reflection of the impact of expressive suppression as affect was not assessed in direct relation
to the negative event. Otherwise, it may be that social context does not influence the impact
of expressive suppression on either positive or negative affect. If it is the latter case, then the
internal consequences of expressive suppression (i.e., affect) may not be influenced by social
context. Therefore, it may be important to make a distinction between external and internal
influences and consequences when it comes to expressive suppression.
The findings for both hypotheses did not differ between patients and controls, suggesting
that social context influences the use of expressive suppression in similar ways for both
patients and controls. This lack of differences could be explained by the fact that the ESM data
was collected at six-year follow-up and most of the patients included in this study were then in
remission. Thus, it is possible that remitted patients are comparable to controls in the use of
expressive suppression. This could imply that expressive suppression is subject to change and
that there might be possible improvements in this area. For instance, it has been shown that
the frequency of expressive suppression decreases with treatment, albeit for social anxiety [26].
There were also no significant differences in the main outcome measures between remitted
and non-remitted patients, which could suggest that the patient group is relatively well-func-
tioning. This may be an effect of choosing participants who completed enough questionnaires
or these measures are not very sensitive to illness severity. However, these explanations are ten-
tative, and more research is needed to further investigate these speculations.
The results of this study should be considered preliminary and interpreted with some
methodological considerations in mind. First, many participants and observations had to be
excluded to obtain a valid sample for the questions of this study, leading to a relatively small
sample. Especially for models including interaction terms, the analyses may have been
Table 3. The association of expressive suppression and positive affect depending on social contexta.
Outcome: Daily positive affect
Social Context adj. β (95% CI) p LR testb,c,d
χ2 (df) p
Company x Expressive suppression 3.208 (-1.74–8.15) .204 1.61 (1) .204
Feedback x Expressive suppression 0.855 (-1.27–2.97) .430 0.62 (1) .431
Company x Feedback x Expressive suppression 0.010 (-4.80–4.82) .997 5.02 (4) .285
CI, confidence interval; df, degrees of freedom; LR, likelihood ratio
a Adjusted for age and gender
b LR test (a nested in b): model a (company, expressive suppression) vs model b (company x expressive suppression)
c LR test (a nested in b): model a (feedback, expressive suppression) vs model b (feedback x expressive suppression);
d LR test (a nested in b): model a (company, feedback, expressive suppression) vs model b (company x feedback x
expressive suppression)
https://doi.org/10.1371/journal.pone.0230102.t003
Table 4. Stratified associations between groups (Table 3).
Social Context Patients Controls
adj. β (95% CI) p adj. β (95% CI) p
Company x Expressive suppression -19.57 (-55.02–15.88) .279 3.62 (-32.77–40.01) .845
Feedback x Expressive suppression -1.92 (-5.9–2.06) .345 3.00 (-0.37–6.37) .081
Company x Feedback x Expressive suppression 4.77 (-1.90–11.44) .161 -0.40 (-6.92–6.13) .905
https://doi.org/10.1371/journal.pone.0230102.t004
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underpowered as the numbers of participants in the individual cells were quite small. Second,
expressive suppression and social context were measured once at the end of the day, which may
not directly capture the dynamics of an individual in a given context but rather reflect on the
whole day: the evaluation of the day could then be influenced by other events during the day
and potentially increase or decrease the impact of the chosen negative event. It is therefore
unknown how the negative event was specifically related to the level of positive and negative
affect, which may also explain some of the null findings. Third, this study investigated responses
only to negative events although it has been suggested to investigate responses to positive events
as well [18]. However, negative events are focused on given its greater clinical relevance as the
reactivity to daily stressors plays an important role in psychosis. For instance, it is fairly estab-
lished that there is an affective pathway from daily stressors to psychotic symptoms [27, 28];
the affective reaction to a stressor may then be influenced by emotion regulation. Nonetheless,
positive events should be studied as this knowledge could contribute to the understanding of
expressive suppression and the regulation of emotions in psychosis, which may be of scientific
interest.
This study adds to the understanding of expressive suppression as an emotion regulation
strategy through a daily life perspective, measuring it as a variable strategy rather than as habit-
ual strategy. This was done with ESM, which is more ecologically valid as opposed to other
methods [29,30], such as investigating experimentally-induced expressive suppression in lab
settings or measuring expressive suppression with a one-time questionnaire, such as the Emo-
tion Regulation Questionnaire (ERQ; 7). Furthermore, while this study investigates only two
aspects of social context, including social context acknowledges that emotion regulation does
not occur in a vacuum and that one’s surroundings, including other people, can influence how
expressive suppression is used by individuals. In addition, investigating these questions in a
sample with patients is imperative as deficits in emotion regulation are apparent in psychosis.
Table 5. The association of expressive suppression and negative affect depending on social contexta.
Outcome: Daily negative affect
Social Context adj. β (95% CI) p LR testb,c,d
χ2 (df) p
Company x Expressive suppression -0.021 (-2.76–2.71) .988 0.00 (1) .988
Feedback x Expressive suppression 0.050 (-1.06–1.16) .929 0.01 (1) .929
Company x Feedback x Expressive suppression -0.391 (-2.89–2.11) .759 0.53 (4) .970
CI, confidence interval; df, degrees of freedom; LR, likelihood ratio
a Adjusted for age and gender
b LR test (a nested in b): model a (company, expressive suppression) vs model b (company x expressive suppression)
c LR test (a nested in b): model a (feedback, expressive suppression) vs model b (feedback x expressive suppression);
d LR test (a nested in b): model a (company, social feedback, expressive suppression) vs model b (company x
feedback x expressive suppression)
https://doi.org/10.1371/journal.pone.0230102.t005
Table 6. Stratified associations between groups (Table 5).
Social Context Patients Controls
adj. β (95% CI) p adj. β (95% CI) p
Company x Expressive suppression -11.63 (-33.79–10.52) .303 8.40 (-8.35–25.15) .326
Feedback x Expressive suppression -1.17 (-3.66–1.31) .356 0.90 (-0.65–2.44) .256
Company x Feedback x Expressive suppression 1.53 (-2.64–5.70) .472 -1.24 (-4.24–1.76) .418
https://doi.org/10.1371/journal.pone.0230102.t006
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This study extends previous work in emotion regulation, specifically expressive suppression,
using ESM (e.g., 9, 18) by including a clinical sample.
Further research can first focus on replicating our results with a larger sample and more
measurement periods is necessary for more concrete evidence. Second, future studies should
investigate the use of expressive suppression and other emotion regulation techniques over
the course of illness in a clinical population with psychotic disorders to understand if and how
they change over time. Third, considering the mechanisms of emotion regulation on affective
disturbances in different contexts and how they lead to specific psychotic symptoms could give
a more nuanced perspective of the development and maintenance of psychotic psychopathol-
ogy. Overall, these future studies could lead to more fully-fledged models by taking the differ-
ent stages, pathways, and processes that play a role in psychosis.
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